.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
QuintilesIMS
Teva
Daiichi Sankyo
Cerilliant
Fish and Richardson
Cantor Fitzgerald
Healthtrust
McKinsey

Generated: December 12, 2017

DrugPatentWatch Database Preview

Probenecid - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for probenecid and what is the scope of probenecid freedom to operate?

Probenecid
is the generic ingredient in three branded drugs marketed by Merck, Lannett, Ivax Sub Teva Pharms, Lederle, Mylan, Watson Labs, and Watson Labs Teva, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for probenecid. Ten suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for probenecid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Watson LabsPROBENECIDprobenecidTABLET;ORAL086150-002Apr 23, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettPROBALANprobenecidTABLET;ORAL080966-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsPROBENECIDprobenecidTABLET;ORAL083740-001May 9, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MerckBENEMIDprobenecidTABLET;ORAL007898-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
LederlePROBENECIDprobenecidTABLET;ORAL086917-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson Labs TevaPROBENECIDprobenecidTABLET;ORAL084442-004Mar 29, 1983ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanPROBENECIDprobenecidTABLET;ORAL084211-002Approved Prior to Jan 1, 1982ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
Fuji
Merck
QuintilesIMS
Federal Trade Commission
Chinese Patent Office
Argus Health
Cantor Fitzgerald
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot